Login
$PSBD
$9.92 +$0.07 (0.71%) Close

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Oct 14, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Assets:
Non-controlled, non-affiliated investments, at fair value (amortized cost of $1,242,154,554 and $1,294,556,070, respectively)
Cash and cash equivalents
Receivables:
Receivable for sales of investments
Receivable for paydowns of investments
Due from investment adviser
Dividend receivable
Interest receivable
Prepaid expenses and other assets
Total Assets
Liabilities:
Credit facilities (net of deferred financing costs of $4,214,138 and $5,030,068, respectively) (Note 6)
Notes (net of deferred financing costs of $1,540,292 and $1,609,420, respectively) (Note 6)
Payables:
Payable for investments purchased
Distributions payable
Management fee payable
Incentive fee payable
Accrued other general and administrative expenses
Total Liabilities
Net Assets:
Common Shares, $0.001 par value; 450,000,000 shares authorized; 30,743,081 and 31,260,963 as of June 30, 2026 and December 31, 2025, respectively issued and outstanding
Additional paid-in capital
Total distributable earnings (accumulated deficit)
Total Net Assets
Total Liabilities and Net Assets
Net Asset Value Per Common Share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support